DRL launches muscle disease drug in US
The company's product is the generic version of Bloxiverz Injection
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Global Interstitial Cystitis, Bladder Pain Society concludes 3rd annual scientific conference
The objective was to strengthen the existing working principles and take the plunge to innovative steps in the management of…
Over 9500 visitors attend India Lab expo, analytica Anacon India and Pharma Pro&Pack expo 2018
There were around 261 exhibitors from India and overseas at the trade fair trio
Health Ministry prohibits manufacture or distribution for human use of 328 FDCs
The Drugs Technical Advisory Board recommended, amongst other things, that these FDCs may involve risk to human beings
Green ChemisTree Foundation, GCIPR to organise technical conference
The objective of the conference is to enable greater business value for Indian pharma API and bulk intermediate manufacturers
Sun Pharma’s Mohali plant on FDA radar
Recently, the USFDA had issued Form 483 with six observations after an inspection of the company's Halol facility in Gujarat
Zydus Cadila gets tentative nod from USFDA for diabetes drug
The company has received tentative approval from the USFDA for Sitagliptin tablets in strengths of 25 mg, 50 mg, and 100 mg, Zydus…
Sun Pharma arm to acquire shares of Israeli firm Tarsius Pharma for $3 mn
Indicative time period for completion of the acquisition is before September 15, 2018, Sun Pharma said
National Insulin Summit draws over 300 Indian doctors to discuss innovations in insulin therapy
How early and appropriate use of insulin can not only prevent short-term complications, but also reduce long-term morbidity and…
India Tech Conclave to focus on possibilities enabled by AI & Automation
The conclave will look at various components that are essential to the making of a good manufacturing process enabled by AI and…